加速“接入”现实！脑机接口迈入产业化快车道

Core Insights - The article discusses the advancements in brain-computer interface (BCI) technology in China, highlighting significant clinical trials and the potential for industry growth by 2025 [1][5]. Group 1: Technological Advancements - The second clinical trial of an invasive brain-computer interface has successfully allowed patients with high-level paraplegia to control devices using their thoughts, marking a shift from 2D screen control to 3D physical interactions [1]. - The second-generation BCI product released by Shanghai Ladder Medical Technology Co., Ltd. has increased the number of signal channels from 64 to 256, improving interaction efficiency by approximately 60% [2]. - Breakthroughs in core components and decoding algorithms have been achieved, with increased channel counts and improved stability in BCI chips and implanted electrodes [2]. Group 2: Application Scenarios - BCI technology is being rapidly industrialized, with applications expanding into various fields, including treatment for autism in children, where devices can assess brain function and stimulate abnormal neural circuits [3]. - Invasive BCIs are primarily focused on medical applications, with numerous clinical cases addressing spinal cord injuries and stroke rehabilitation, while non-invasive BCIs are being developed for consumer and industrial applications [3]. Group 3: Policy and Industry Development - The establishment of the "Brain Intelligence World" industrial cluster in Shanghai aims to foster collaboration among nearly 20 teams and enterprises, with an initial investment of 1.2 billion yuan [4]. - The Chinese government has set ambitious goals for the BCI industry, aiming for significant innovation and global competitiveness by 2030, alongside the introduction of new medical device standards [4][5]. - The BCI market in China is expected to exceed 3.8 billion yuan by 2025, with over 200 companies currently operating in the sector [5].